Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
PLXShowing 5 of 10 quarters
Position history for Bank of New York Mellon Corp's holdings in PROTALIX BIOTHERAPEUTICS INC
Bank of New York Mellon Corp holds 232,992 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $542,871 as of 2026-Q2. The position was increased (+6.2% shares). PLX represents 0.0% of Bank of New York Mellon Corp's portfolio.
Current Value
$542,871
Current Shares
232,992
Total Value Change
+$344,126
Total Shares Change
+98,705
Quarter-by-Quarter History
Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.